JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
513 * | Wed, 8/1/2012, 10:30 AM - 12:20 PM | CC-Room 24B | |
Interim Analysis Methods and Innovations — Contributed Papers | |||
Biopharmaceutical Section | |||
Chair(s): A. Lawrence Gould, Merck | |||
10:35 AM | Multivariate B-Value: A Tool for Monitoring Data with Multiple Co-Primary Endpoints — Yansong Cheng, Boston University ; Surajit Ray, Boston University ; Ying Zhu, Biogen Idec | ||
10:50 AM | An Efficiency Ratio for Criteria Selection in Futility Assessment of Clinical Trials — Jianliang Zhang, MedImmune | ||
11:05 AM | Data Monitoring in Clinical Trials Using Innovative and Practical Bayesian Tool — Soumi Lahiri, GlaxoSmithKline | ||
11:20 AM | Predictive Power for Group Sequential Trials with Different Endpoint at Interim Look — Shengyan Hong, MedImmune ; Songfeng Wang, University of South Carolina | ||
11:35 AM | Predicting the Event Time in Multicenter Clinical Trials with Time-to-Event Outcome as Primary Endpoint — Nibedita Bandyopadhyay, Janssen Pharmaceuticals R&D | ||
11:50 AM | Closed Tests for Multi-Arm Phase II Oncology Trials — Karen Messer, University of California at San Diego ; Hongying Li, University of California at San Diego ; Minya Pu, University of California at San Diego | ||
12:05 PM | The Case for Bayesian Predictive Probabilities for Interim Monitoring of Clinical Trials — Benjamin Saville, Vanderbilt University School of Medicine ; Jason Connor, Berry Consultants ; Gregory Ayers, Vanderbilt University School of Medicine ; JoAnn Alvarez, Vanderbilt University School of Medicine |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.